• Alexander Pharma
  • Slideimages02-EN

Erythropoietin

 

Active Principle

Recombinant human Eruythropoietin alpha

Presentation

 

 

2000 IU

4000 IU

10000 IU

Indication

Treatment of anemia associated with CRF, to elevate or maintain the red blood cell level and to decrease the need for transfusions in these patients.

Class

H